Heart failure with mid-range or mildly reduced ejection fraction
G Savarese, D Stolfo, G Sinagra, LH Lund - Nature Reviews Cardiology, 2022 - nature.com
Left ventricular ejection fraction (EF) remains the major parameter for diagnosis,
phenotyping, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …
phenotyping, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …
Survival of patients with chronic heart failure in the community: a systematic review and meta‐analysis
NR Jones, AK Roalfe, I Adoki… - European journal of …, 2019 - Wiley Online Library
Aim To provide reliable survival estimates for people with chronic heart failure and explain
variation in survival by key factors including age at diagnosis, left ventricular ejection …
variation in survival by key factors including age at diagnosis, left ventricular ejection …
[HTML][HTML] Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America
Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of
America - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
America - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure―digest version―
H Tsutsui, M Isobe, H Ito, K Okumura, M Ono… - Circulation …, 2019 - jstage.jst.go.jp
Heart Failure Society (JHFS). The working committee for this project includes members and
collaborators involved in the previous versions of the heart failure guidelines and members …
collaborators involved in the previous versions of the heart failure guidelines and members …
Epidemiology of heart failure with preserved ejection fraction
SM Dunlay, VL Roger, MM Redfield - Nature Reviews Cardiology, 2017 - nature.com
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome associated
with poor quality of life, substantial health-care resource utilization, and premature mortality …
with poor quality of life, substantial health-care resource utilization, and premature mortality …
Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart …
O Chioncel, M Lainscak, PM Seferovic… - European journal of …, 2017 - Wiley Online Library
Aims The objectives of the present study were to describe epidemiology and outcomes in
ambulatory heart failure (HF) patients stratified by left ventricular ejection fraction (LVEF) and …
ambulatory heart failure (HF) patients stratified by left ventricular ejection fraction (LVEF) and …
[PDF][PDF] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …
Epidemiology and aetiology of heart failure
B Ziaeian, GC Fonarow - Nature Reviews Cardiology, 2016 - nature.com
Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of>
37.7 million individuals globally. HF is a shared chronic phase of cardiac functional …
37.7 million individuals globally. HF is a shared chronic phase of cardiac functional …
Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
Aims We tested the hypothesis that candesartan improves outcomes in heart failure (HF)
with mid‐range ejection fraction [HFmrEF; ejection fraction (EF) 40–49%]. Methods and …
with mid‐range ejection fraction [HFmrEF; ejection fraction (EF) 40–49%]. Methods and …
Mitochondrial function as a therapeutic target in heart failure
DA Brown, JB Perry, ME Allen, HN Sabbah… - Nature Reviews …, 2017 - nature.com
Heart failure is a pressing worldwide public-health problem with millions of patients having
worsening heart failure. Despite all the available therapies, the condition carries a very poor …
worsening heart failure. Despite all the available therapies, the condition carries a very poor …